The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis
Abstract
Objective: Although mortality among patients with rheumatoid arthritis (RA) is higher than in the general population, the relative contribution of comorbid diseases to this mortality difference is not known. This study was undertaken to evaluate the contribution of congestive heart failure (CHF) and ischemic heart disease (IHD), including myocardial infarction, to the excess mortality in patients with RA, compared with that in individuals without RA. Methods: We assembled a population‐based inception cohort of individuals living in Rochester, Minnesota, in whom RA (defined according to the criteria of the American College of Rheumatology [formerly, the American Rheumatism Association]) first developed between 1955 and 1995, and an age‐ and sex‐matched non‐RA cohort. All subjects were followed up until either death, migration from the county, or until 2001. Detailed information from the complete medical records was collected. Statistical analyses included the person‐years method, cumulative incidence, and Cox regression modeling. Attributable risk analysis techniques were used to estimate the number of RA deaths that would be prevented if the incidence of CHF was the same in patients with RA and non‐RA subjects. Results: The study population included 603 patients with RA and 603 subjects without RA. During followup, there was an excess of 123 deaths among patients with RA (345 RA deaths occurred, although only 222 such deaths were expected). The mortality rates among patients with RA and non‐RA subjects were 39.0 and 29.2 per 1,000 person‐years, respectively. There was a significantly higher cumulative incidence of CHF (but not IHD) in patients with RA compared with non‐RA subjects (37.1% versus 27.7% at 30 years of followup, respectively; P < 0.001). The risk of death associated with either CHF or IHD was not significantly different between patients with RA and non‐RA subjects. If the risk of developing CHF was the same in patients with RA and individuals without RA, the overall mortality rate difference between RA and non‐RA hypothetically would be reduced from 9.8 to 8.0 excess deaths per 1,000 person‐years; that is, 16 (13%) of the 123 excess deaths could be prevented. Conclusion: CHF, rather than IHD, appears to be an important contributor to the excess overall mortality among patients with RA. CHF contributes to this excess mortality primarily through the increased incidence of CHF in RA, rather than increased mortality associated with CHF in patients with RA compared with non‐RA subjects. Eliminating the excess risk of CHF in patients with RA could significantly improve their survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155 · cited 1×
“According to the results of the Framingham study (29) and the Cardiovascular Health Study (30), the factors that contribute most to CHF in the general population are hypertension and coronary heart disease, followed by diabetes, smoking, and other factors.”
ResultLong-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · cited 4×
“The potential of this data source for use in population-based research has been previously described (11,12).”
BackgroundMethodInfluentialPredictors of congestive heart failure in the elderly: the Cardiovascular Health Study
Gottdiener, J. S., Arnold, A. M., Aurigemma, G. P., Polak, J. F., Tracy, R. P., Kitzman, D. W., Gardin, J. M., Rutledge, J. E., & Boineau, R. C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00582-9 · Cited by 907
Cited by
Bongartz, T., Nannini, C., Medina‐Velasquez, Y. F., Achenbach, S. J., Crowson, C. S., Ryu, J. H., Vassallo, R., Gabriel, S. E., & Matteson, E. L. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27405 · Cited by 864
Self-citationInnate Immunity and the Failing Heart: The Cytokine Hypothesis Revisited
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 689
Comorbidities in rheumatoid arthritis
Michaud, K., & Wolfe, F. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.06.002 · Cited by 400
Gonzalez, A., Kremers, H. M., Crowson, C. S., Ballman, K. V., Roger, V. L., Jacobsen, S. J., O'Fallon, W. M., & Gabriel, S. E. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.059980 · Cited by 316
Self-citationCardiovascular Morbidity and Mortality in Rheumatoid Arthritis
Gabriel, S. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.011 · Cited by 315
Self-citation
Metadata
- Authors
- Nicola, P. J., Crowson, C. S., Maradit‐Kremers, H., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-12-29
- Volume
- 54
- Issue
- 1
- Pages
- 60-67
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2062132149
- Cited by
- 189
- References
- 6
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.21560
- The paper
- Nicola, P. J., Crowson, C. S., Maradit‐Kremers, H., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E. (2006). Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.21560
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.